½ÃÀ庸°í¼­
»óǰÄÚµå
1673085

½Ã¸°Áö ½ÃÀå : ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Syringe Market, By Usage, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ½Ã¸°Áö ½ÃÀåÀº 2025³â¿¡ 240¾ï 7,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 454¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR)Àº 9.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 240¾ï 7,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 9.50% 2032³â ±Ý¾× ¿¹Ãø 454¾ï 6,000¸¸ ´Þ·¯
µµÇ¥. 2025³â Áö¿ªº° ÁÖ»ç±â ½ÃÀå Á¡À¯À²(%)
Syringe Market-IMG1

¼¼°è ÁÖ»ç±â ½ÃÀåÀº Áö³­ ¼ö½Ê³â°£ ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÁÖ»ç±â´Â ÀÎü¿¡ ÁÖ»çÇϰųª ü¾×À» ÃßÃâÇÏ´Â µ¥ ÇʼöÀûÀÎ ¾×¼¼¼­¸®ÀÔ´Ï´Ù. ÁÖ»ç±â´Â ¹è·²ÀÇ ¿øÅëÇü Æ©ºê¿Í Ç÷±Àú¿¡ ºÎÂøµÈ Áß°ø ¹Ù´Ã·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ÁÖ»ç±â´Â ÀÇ·á ½Ã¼ú½Ã ¹é½ÅÀ̳ª Àν¶¸°°ú °°Àº ¾à¹°À» Åõ¿©ÇÏ´Â µ¥ ³Î¸® »ç¿ëµË´Ï´Ù. ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯ¿¡ °É¸®±â ½¬¿î °í·ÉÈ­ Àα¸ Áõ°¡¿¡ µû¸¥ Àα¸ Åë°èÇÐÀû º¯È­·Î ÀÎÇØ ÁÖ»ç±â ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è¿¡¼­ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥ Áõ°¡¿Í ÇÔ²² Àü¿°º´ÀÇ È®»êÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÁÖ»ç±â Àç»ç¿ë ¹× Æó±â¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦´Â ½ÃÀå Âü¿©Àڵ鿡°Ô µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù. º¸´Ù »ç¿ëÇϱ⠽±°í ºñ¿ë È¿À²ÀûÀÎ ÁÖ»ç±â °³¹ßÀ» À§ÇÑ ½ÅÈï ±¹°¡ ½ÃÀå °³¹ßÀº ÇâÈÄ ¼ö³â°£ ½ÃÀå È®´ëÀÇ »õ·Î¿î ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è ÁÖ»ç±â ½ÃÀåÀº ÁÖ·Î ¸¸¼ºÁúȯ ¹× °¨¿°¼º ÁúȯÀÇ Àü ¼¼°è À¯º´·ü Áõ°¡·Î ÀÎÇØ ÀÇ·á »ê¾÷¿¡¼­ ÁÖ»ç±â ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃßÁ¤¿¡ µû¸£¸é ¸¸¼ºÁúȯÀº ¿¬°£ 1¾ï 4,300¸¸ ¸í ÀÌ»óÀÇ ¹Ì±¹ÀÎÀ» ±«·ÓÈ÷¸ç, ¹Ì±¹ Àüü ÀÇ·áºñÀÇ 50% ÀÌ»óÀ» Â÷ÁöÇÕ´Ï´Ù. ƯÈ÷ ´ç´¢º´Àº ¹Ì±¹¿¡¼­¸¸ 3,000¸¸ ¸í ÀÌ»óÀÌ ¾Î°í ÀÖÀ¸¸ç, °øÁߺ¸°Ç¿¡ Å« ¹®Á¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â Àν¶¸° ÁÖ»ç±â ¼ö¿ä¸¦ Å©°Ô Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¼±Áø±¹°ú ½ÅÈï ±¹°¡À» ¸··ÐÇϰí Á¤ºÎ¿Í ÀÇ·á±â°üÀÌ ¿¹¹æÁ¢Á¾ ¹× ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥À» Áß¿ä½ÃÇÏ´Â °æÇâÀÌ °­È­µÇ°í ÀÖ´Â °Íµµ ½ÃÀå °³¹ß¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÁÖ»ç±â Æó±â ¹× Àç»ç¿ëÀ» °ü¸®ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦´Â ½ÃÀå °ü°èÀڵ鿡°Ô Å« Á¦¾à ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, º¸´Ù »ç¿ëÇϱ⠽±°í Àú·ÅÇÑ ÁÖ»ç±â¸¦ °³¹ßÇϱâ À§ÇÑ ¿¬±¸°³¹ßÀÌ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ½ÃÀå È®´ëÀÇ »õ·Î¿î ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù. ÁÖ»ç±â Á¦Á¶¾÷üµéÀº ÀÎü°øÇÐ ¹× ¾ÈÀü¼ºÀ» °³¼±ÇÑ Á¦Ç°À» ¼³°èÇϰí, ¾à¹°ÀÌ ¹Ì¸® ä¿öÁø Á¦Ç°À» Á¦°øÇÔÀ¸·Î½á ÁÖ»ç±â äÅÃÀ» ´Ã¸®°í ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ ÁÖ»ç±â(ÁÖ»ç±â) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¸ÅÃâ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ÁÖ»ç±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ÁÖ»ç±â ½ÃÀåÀº ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ÁÖ»ç±â ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • °³¿ä
  • COM(Coherent Opportunity Map)(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • ÀÚ±ÝÁ¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ½Ã¸°Áö ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ ±¸»ó
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½Ã¸°Áö ½ÃÀå, ¿ëµµº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ¸ê±Õ °¡´É/Àç»ç¿ë °¡´É ½Ã¸°Áö
  • ÀÏȸ¿ë ½Ã¸°Áö
  • ÇÁ¸®ÇÊµå ½Ã¸°Áö

Á¦6Àå ¼¼°èÀÇ ½Ã¸°Áö ½ÃÀå, ¿ëµµº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • Àν¶¸° ½Ã¸°Áö
  • º¸Å彺
  • °ñ°üÀý¿°
  • Àΰ£¼ºÀåÈ£¸£¸ó
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ½Ã¸°Áö ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • º´¿ø
  • Ŭ¸®´Ð
  • ÀçÅà ÀÇ·á
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ½Ã¸°Áö ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • ICU Medical, Inc.
    • CODAN Companies
    • Catalent, Inc.
    • BD
    • Hindustan Syringes & Medical Devices Ltd
    • Terumo Corporation
    • Schott AG
    • Cardinal Health
    • B. Braun SE
    • Gerresheimer AG
    • NIPRO
    • Gerresheimer AG
    • Dali Medical Devices
    • Zephyrus Innovations(Zephyrus)
    • Stevanato Group
    • Xellia Pharmaceuticals
    • Delta Med Group

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ ½ÃÁ¡

  • ¿î¸íÀÇ ¼ö·¹¹ÙÄû
  • COM(Coherent Opportunity Map)

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
KSA 25.04.02

Global Syringe Market is estimated to be valued at USD 24.07 Bn in 2025 and is expected to reach USD 45.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 24.07 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.50% 2032 Value Projection: USD 45.46 Bn
Figure. Syringe Market Share (%), By Region 2025
Syringe Market - IMG1

The global syringe market has been witnessing steady growth over the past few decades. A syringe is an essential accessory used for injecting or extracting fluids from the human body. It consists of a hollow needle attached to a cylindrical tube and plunger within a barrel. Syringes find widespread application for delivering medications such as vaccines, insulin, and others during medical procedures. Changing demographics with rising aging population susceptible to chronic diseases like diabetes have significantly boosted the demand for syringes. Moreover, the growing prevalence of infectious diseases coupled with increasing immunization programs across the globe acts as a key growth driver for the market. However, stringent regulations concerning the reuse and disposal of syringes pose a challenge to market players. Ongoing technological innovations aimed at developing more user-friendly and cost-effective syringes are expected to provide new opportunities for market expansion in the coming years.

Market Dynamics:

The global syringe market is primarily driven by rising incidence of chronic and infectious diseases worldwide which has increased the demand for syringes from the healthcare industry. According to estimates, chronic diseases affect over 143 million Americans annually, accounting for more than 50% of the total healthcare spending in the country. Diabetes, in particular, has emerged as a major public health concern affecting over 30 million people in the U.S. alone. This is expected to significantly boost the demand for insulin syringes. Furthermore, growing emphasis on immunization and vaccination programs by governments and healthcare agencies across both developed and developing nations is favoring the market growth. However, stringent regulations governing the disposal and reuse of syringes acts as a major restraining factor for market players. On the other hand, ongoing R&D to develop more user-friendly and affordable syringes provides new opportunities for market expansion. Syringe manufacturers are designing products with improved ergonomics, safety features, and offerings prefilled with drugs to increase adoption of syringes.

Key Features of the Study:

  • This report provides an in-depth analysis of the global syringe market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global syringe market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include ICU Medical, Inc., CODAN Companies, Catalent, Inc., BD, Hindustan Syringes & Medical Devices Ltd, Terumo Corporation, Schott AG, Cardinal Health, B. Braun SE, Gerresheimer AG, NIPRO, Gerresheimer AG, Dali Medical Devices, Zephyrus Innovations (Zephyrus), Stevanato Group, Xellia Pharmaceuticals, and Delta Med Group.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global syringe market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global syringe market.

Detailed Segmentation-

  • Usage:
    • Sterilizable/Reusable Syringes
    • Disposable Syringes
    • Prefilled Syringes
  • Application:
    • Insulin Syringes
    • Botox
    • Osteoarthritis
    • Human Growth Hormone
    • Others
  • End User:
    • Hospitals
    • Clinics
    • Homecare Settings
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • ICU Medical, Inc.
    • CODAN Companies
    • Catalent, Inc.
    • BD
    • Hindustan Syringes & Medical Devices Ltd
    • Terumo Corporation
    • Schott AG
    • Cardinal Health
    • Braun SE
    • Gerresheimer AG
    • NIPRO
    • Gerresheimer AG
    • Dali Medical Devices
    • Zephyrus Innovations (Zephyrus)
    • Stevanato Group
    • Xellia Pharmaceuticals
    • Delta Med Group

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Usage
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Pricing Analysis
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Syringe Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 impact on the market

5. Global Syringe Market, By Usage, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Sterilizable/Reusable Syringes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Disposable Syringes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prefilled Syringes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Syringe Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Insulin Syringes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Botox
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Osteoarthritis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Human Growth Hormone
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Syringe Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Homecare Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Syringe Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Company Profiles
    • ICU Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • CODAN Companies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Catalent, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • BD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Hindustan Syringes & Medical Devices Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Schott AG
    • Cardinal Health
    • B. Braun SE
    • Gerresheimer AG
    • NIPRO
    • Gerresheimer AG
    • Dali Medical Devices
    • Zephyrus Innovations (Zephyrus)
    • Stevanato Group
    • Xellia Pharmaceuticals
    • Delta Med Group

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact

"

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦